Adolescent CB1 receptor expression at the BLA and CA1 and acute AM251 effects on sociability and emotional memory are sex-specific, and not modulated by heterotypic stress exposure.

Behav Brain Res

Cerebro Vascular Accidents and Behavioural Recovery Laboratory, School of Psychology, University of Ottawa, Ottawa, Canada. Electronic address:

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Blockade of endocannabinoid CB1R has shown effects on adulthood sociability, memory and fear responses, under basal and stress conditions. In this study, we examined sex-specific effects of exposure to heterotypic stress in the prepubescent period, marked by maturation of brain systems, on endocannabinoid receptors expression, corticosterone secretion and effects of CB1 receptor blockade on social and cognitive responses. Sixty-four (N = 32 per sex) adolescent male and female rats were randomly assigned to a stress or no stress condition. Rats in the stress condition underwent a 10-day heterotypic stress paradigm alternating between restraint stress and forced swim exposure occurring between postnatal day (PND) 30 and PND39. On PND42 and PND44, rats pretreated with the cannabinoid 1 receptor (CB1) antagonist AM251 (1 mg/kg; i.p.) or a vehicle solution underwent behavioural testing in the social interaction and the Y-Maze passive avoidance tests. Our findings indicated acute CB1 antagonism to reduce sociability and fear memory, independently of sex or stress. Notably, baseline and stress-related corticosterone (CORT) detection indicated adolescent male to more rapidly habituate to stress exposure than female rats. Male rats also showed increased CB1 receptor expression at the basolateral amygdala and CA1 regions, although GR-ir remained unaltered. Together, our findings support observed sex- and region- specific differences in CB1 receptor expression during the adolescence period to be minimally influenced by prior heterotypic stress exposure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbr.2025.115704DOI Listing

Publication Analysis

Top Keywords

cb1 receptor
16
heterotypic stress
16
receptor expression
12
stress exposure
12
stress
11
adolescent male
8
female rats
8
stress condition
8
receptor
5
exposure
5

Similar Publications

Traditional drug discovery methods like high-throughput screening and molecular docking are slow and costly. This study introduces a machine learning framework to predict bioactivity (pIC₅₀) and identify key molecular properties and structural features for targeting Trypanothione reductase (TR), Protein kinase C theta (PKC-θ), and Cannabinoid receptor 1 (CB1) using data from the ChEMBL database. Molecular fingerprints, generated via PaDEL-Descriptor and RDKit, encoded structural features as binary vectors.

View Article and Find Full Text PDF

Exogenous cannabinoids have long been known to promote eating. However, the underlying mechanisms have not been completely elucidated, which is critical to understanding their utility. The orexin/hypocretin (OH) system of the lateral hypothalamus (LHA) has known anatomical, biochemical, and physiological interactions with the endocannabinoid system, and has an established role in promoting appetitive behavior; yet, it is still unknown if the OH system mediates food intake following cannabinoid administration.

View Article and Find Full Text PDF

Identification of Tetrahydrocannabidiol Metabolites in Human Urine.

Drug Test Anal

September 2025

Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Bern, Switzerland.

Tetrahydrocannabidiol (H4CBD) is an emerging semisynthetic cannabinoid, which has been known since 1940. Like hexahydrocannabinol (HHC), it is easily obtained by hydrogenation of available phytocannabinoids, in the case of H4CBD by hydrogenation of cannabidiol (CBD). H4CBD shows a weak affinity for the CB receptor, but it is unclear if H4CBD shows psychoactive properties, as reports from users are divided.

View Article and Find Full Text PDF

State of the Art Review: Thiazide diuretics exploit the endocannabinoid system via NAPE-PLD.

Am J Hypertens

September 2025

Laboratori ALIVEDA, Viale Karol Wojtyla 19, 56042 Crespina Lorenzana, Pisa, Italy.

The present State of the Art Review will take stock of targeting the endocannabinoid system (ECS) in the management of hypertension and vascular diseases. Major efforts have been made in the last thirty years to develop compounds modulating the ECS for diseases, both in the central and peripheral tissues. Agonists of the cannabinoid receptor CB1 elicited hypotension but were at strong risks of inducing tachycardia, heart and kidney damage.

View Article and Find Full Text PDF

Cognitive decline is a hallmark of Alzheimer's disease (AD). Cannabidiol (CBD), a non-intoxicating phytocannabinoid with immunomodulatory properties, shows promise in alleviating AD symptoms. This study examined the effects of chronic CBD treatment in a male rat model of sporadic AD induced by intracerebroventricular streptozotocin (ICV-STZ) and explored its impact on neuroinflammatory genes and cannabinoid signaling.

View Article and Find Full Text PDF